Research library / Resveratrol and sirtuins

CC Small or few human trials. Promising, not proven. How we grade →RCT · 45 postmenopausal women randomized (15 resveratrol, 14 placebo analyzed)

Resveratrol supplementation does not improve metabolic function in nonobese women with normal glucose tolerance

J Yoshino, C Conte, L Fontana, B Mittendorfer, S Imai, K Schechtman et al. Cell Metabolism. 2012.

Published Sources checked 1 sourceEverstack research teamHow we work

In plain language
75 mg of resveratrol a day for 12 weeks raised blood resveratrol but did not change insulin sensitivity on the clamp test, body composition, metabolic rate, lipids, inflammatory markers or SIRT1 and AMPK in muscle and fat.
Limits
Small, low dose, healthy women only. Funded by NIH, DSM and the Longer Life Foundation; DSM supplied resVida, one author was a DSM employee, another advised Sirtris.
Which of our grades it feeds
Source
doi.org/10.1016/j.cmet.2012.09.015 · PubMed 23102619 · Free full text

Summary written by Everstack from the published abstract. Verified against Crossref on 2026-10-15. The authors do not endorse Everstack. We sell some of what we grade.